Pulmonary Hypertension and Hyperglycemia—Not a Sweet Combination

Or Bruck,L. M. Pandit

DOI: https://doi.org/10.3390/diagnostics14111119

IF: 3.6

2024-05-29

Diagnostics

Abstract:Hyperglycemia and pulmonary hypertension (PH) share common pathological pathways that lead to vascular dysfunction and resultant cardiovascular complications. These shared pathologic pathways involve endothelial dysfunction, inflammation, oxidative stress, and hormonal imbalances. Individuals with hyperglycemia or pulmonary hypertension also possess shared clinical factors that contribute to increased morbidity from both diseases. This review aims to explore the relationship between PH and hyperglycemia, highlighting the mechanisms underlying their association and discussing the clinical implications. Understanding these common pathologic and clinical factors will enable early detection for those at-risk for complications from both diseases, paving the way for improved research and targeted therapeutics.

medicine, general & internal

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the relationship between hyperglycemia and pulmonary hypertension (PH) and its underlying mechanisms. Specifically, the paper aims to:

1. **Explore the association between hyperglycemia and pulmonary hypertension**: The paper emphasizes the pathophysiological pathways shared by these two diseases, such as endothelial dysfunction, inflammation, oxidative stress and hormonal imbalance, and these common factors lead to vascular dysfunction and cardiovascular complications.

2. **Discuss clinical significance**: By understanding these common pathophysiological and clinical factors, early detection of high - risk populations can be achieved, thereby improving research and targeted treatment.

3. **Reveal bidirectional influence**: The paper points out that there is a bidirectional relationship between hyperglycemia and pulmonary hypertension. Hyperglycemia can exacerbate the development of pulmonary hypertension, and patients with pulmonary hypertension are also more likely to develop insulin resistance and diabetes.

4. **Provide clinical advice**: For patients with both pulmonary hypertension and diabetes, optimizing blood - glucose control and managing comorbidities (such as obesity and obstructive sleep apnea) are crucial for managing these two diseases.

Through these studies, the paper hopes to provide a basis for comprehensive patient care and pave the way for interventions to improve clinical and quality of life.